These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3143632)

  • 1. The usefulness of routine immunological monitoring during the remission phase in acute lymphoblastic leukemias.
    Bontadini A; Gobbi M; Tazzari PL; Raspadori D; Dinota A; Tassi C; Buzzi M; Tura S
    Haematologica; 1988; 73(5):359-64. PubMed ID: 3143632
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute lymphoblastic leukemia in adults: analysis of its clinical forms and course].
    Kotlarek-Haus S; Nowicka J; Radomyska W; Haus O; Weryńska B; Medraś E
    Przegl Lek; 1988; 45(8):609-13. PubMed ID: 3238041
    [No Abstract]   [Full Text] [Related]  

  • 3. [The treatment of acute lymphoblastic leukemias in adults].
    Savchenko VG; Parovichnikova EN; Isaev VG; Kliasova GA; Kucher RA; Sokolov AN; Sarkisian GP; Gal'tseva IV; Ol'shanskaia IuV; Ustinova EN; Gribanova EO; Kokhno AV; Tikhonova LIu; Maslova ER
    Ter Arkh; 1997; 69(7):5-11. PubMed ID: 9424759
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series.
    Ruano D; Diaz MA; Tutor O; Garcia-Sanchez F; Martinez P; Madero L
    Haematologica; 2000 Aug; 85(8):877-8. PubMed ID: 10942942
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. II. Clinical picture and prognosis in specific immunological subgroups].
    Kołecki P; Radwańska U
    Pediatr Pol; 1988 Nov; 63(11):698-702. PubMed ID: 3253656
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of minimal residual disease in acute leukemias by immunophenotyping of bone marrow cells].
    Deptała A; Widzyńska I; Kuratowska Z
    Acta Haematol Pol; 1995; 26(4):403-11. PubMed ID: 8571742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High antileukemic activity of sequential high dose cytosine arabinoside and mitoxantrone in patients with refractory acute leukemias. Results of a clinical phase II study.
    Kern W; Schleyer E; Unterhalt M; Wörmann B; Büchner T; Hiddemann W
    Cancer; 1997 Jan; 79(1):59-68. PubMed ID: 8988727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in adult acute lymphoblastic leukemia (ALL).
    Mazzucconi MG; Amadori S; Mandelli F
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():90-1. PubMed ID: 2713566
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of imatinib mesylate as maintenance therapy in adults with acute lymphoblastic leukemia in first complete remission.
    Potenza L; Luppi M; Riva G; Marasca R; Martinelli S; Torelli G
    Haematologica; 2005 Sep; 90(9):1275-7. PubMed ID: 16154854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute lymphoblastic leukemia in elderly: the Polish Adult Leukemia Group (PALG) experience.
    Robak T; Szmigielska-Kapłon A; Wrzesień-Kuś A; Wierzbowska A; Skotnicki AB; Piatkowska-Jakubas B; Kuliczkowski K; Mazur G; Zduńczyk A; Stella-Hołowiecka B; Hołowiecki J; Dwilewicz-Trojaczek J; Madry K; Dmoszyńska A; Cioch M
    Ann Hematol; 2004 Apr; 83(4):225-31. PubMed ID: 14648030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination.
    Thalhammer-Scherrer R; Mitterbauer G; Simonitsch I; Jaeger U; Lechner K; Schneider B; Fonatsch C; Schwarzinger I
    Am J Clin Pathol; 2002 Mar; 117(3):380-9. PubMed ID: 11888077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial.
    Hunault M; Truchan-Graczyk M; Caillot D; Harousseau JL; Bologna S; Himberlin C; Guyotat D; Berthou C; Casassus P; Baranger L; Béné MC; Ifrah N; Gyan E;
    Haematologica; 2007 Dec; 92(12):1623-30. PubMed ID: 18055985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of the detection of the sL-selectin level in patients with acute leukemia].
    Chang JH; Qi ZH; Xu M
    Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):151-3. PubMed ID: 12575346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute lymphoblastic leukemia in adolescents and young adults in Finland.
    Usvasalo A; Räty R; Knuutila S; Vettenranta K; Harila-Saari A; Jantunen E; Kauppila M; Koistinen P; Parto K; Riikonen P; Salmi TT; Silvennoinen R; Elonen E; Saarinen-Pihkala UM
    Haematologica; 2008 Aug; 93(8):1161-8. PubMed ID: 18556413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
    Paydas S; Tanriverdi K; Yavuz S; Disel U; Baslamisli F; Burgut R
    Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute lymphoblastic leukemia in adults: results of the DATOP-79 protocol].
    Ribera JM; Grañena A; Sierra J; Urbano-Ispizua A; Brugués R; Rozman C
    Med Clin (Barc); 1988 Nov; 91(17):653-7. PubMed ID: 3230971
    [No Abstract]   [Full Text] [Related]  

  • 18. Biology and treatment of acute lymphoblastic leukemia.
    Pieters R; Carroll WL
    Pediatr Clin North Am; 2008 Feb; 55(1):1-20, ix. PubMed ID: 18242313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity.
    Cortes J; Fayad L; O'Brien S; Keating M; Kantarjian H
    Clin Cancer Res; 1999 Sep; 5(9):2491-7. PubMed ID: 10499624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunologic classification of acute leukemias in Puebla city, Mexico: 3 years' experience].
    Ruiz-Argüelles GJ
    Gac Med Mex; 1989; 125(9-10):283-92; discussion 293-4. PubMed ID: 2633956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.